I am a medical oncologist who specializes in research in and treatment of patients with genitourinary malignancies, including bladder, prostate, kidney, and testis cancers. I also have a special interest in understanding the genetic basis for bladder cancer and am a member of Memorial Sloan Kettering’s Bladder Cancer Oncogenome Project, a multidisciplinary effort to discover the key genetic abnormailities that drive this disease. The discovery and understanding of these genetic abnormalities hold the promise of novel treatments for patients with bladder cancer.
- Clinical Expertise: Bladder Cancer; Other Genitourinary Malignancies
- Languages Spoken: English
- Education: MD, Vanderbilt University School of Medicine
- Residencies: University of Michigan Medical Center
- Fellowships: Memorial Sloan Kettering Cancer Center
- Board Certifications: Internal Medicine; Medical Oncology
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more